Noninvasive imaging helps predict heart attacks

March 14, 2017

Noninvasive CT angiography and stress tests can help predict which patients are likely to suffer a heart attack or other adverse cardiovascular event, according to a new study appearing online in the journal Radiology.

Cardiovascular disease is a leading cause of death worldwide. Bypass surgery or stent placement is often recommended in people with certain degrees of coronary arterial narrowing, or stenosis, but recent studies have shown that many of these do just as well with medical therapy. A key factor in treatment decisions is the hemodynamic significance of the lesion, meaning the degree to which the lesion is blocking blood from getting to areas of the heart.

"Previous studies show that a lesion is hemodynamically significant if there is a significant blood pressure drop corresponding to a big reduction in blood flow across the stenosis," said study author João A.C. Lima, M.D., from Johns Hopkins Hospital and School of Medicine in Baltimore. "If plaque has those characteristics, the patient should be targeted for intervention, be it with a stent or downstream ."

A combination of invasive coronary angiography (ICA) and with single photon emission tomography (SPECT) myocardial imaging has been the gold standard for making these determinations, with ICA showing the blockages and SPECT the perfusion, or penetration of the blood into the tissue. However, ICA requires the use of a catheter that is threaded from a puncture point in the groin all the way up to the heart.

"Invasive angiography is generally safe, but it can cause vascular problems in a significant number of patients, most commonly at site of the puncture," Dr. Lima said. "In rare cases, it can cause strokes or heart attacks. These risks are not trivial."

The ICA/SPECT approach can also be expensive, as it often necessitates hospitalization for the patient.

"The traditional approach with invasive catheterization requires that patients go to the hospital, get a catheter inserted into their leg and go in for the nuclear SPECT study on a different day," said study coauthor Marcus Chen, M.D., from the National Institutes of Health in Bethesda, Md. "Now with just one noninvasive test we can get two important but different pieces of information about the coronary arteries."

The researchers set out to determine if combined CT angiography (CTA) and CT myocardial stress perfusion imaging (CTP) could demonstrate similar or superior ability to ICA/SPECT in predicting future adverse events.

They compared the invasive and noninvasive approaches in 379 patients who were referred for ICA from November 2009 to July 2011. The researchers looked at the ability of both techniques to predict whether or not a future major adverse cardiac event (MACE), such as a , revascularization, arrhythmia or hospitalization for chest pain or congestive heart failure would occur.

Fifty-one patients, or 13.5 percent, experienced one or more major adverse cardiac events, including 49 revascularizations, five myocardial infarctions, one cardiac death, nine hospitalizations for chest pain or , and one arrhythmia.

Both techniques proved to have similarly high values for predicting MACE at two years after presentation and event-free survival. The two-year MACE-free rates for combined CT angiography and CT perfusion findings were 94 percent negative for coronary artery disease (CAD) versus 82 percent positive for CAD and were similar to combined ICA/SPECT findings (93 percent negative for CAD vs. 77 percent positive for CAD).

"The key finding of our study is that both techniques are equally effective in identifying which patients are going to have trouble down the road," Dr. Lima said. "The noninvasive option should be a preferred or at least strongly considered option by cardiologists and radiologists managing these patients because it is safer and less expensive, and patients like it better."

Obstacles remain before the noninvasive approach can achieve more widespread use, including the lack of a reimbursement code for stress CT perfusion. But the study indicates that the technique is relatively easy to incorporate into existing practices: 15 of the 16 centers in the trial had never done the procedure before, according to Dr. Chen, and all were all able to learn it effectively.

Explore further: Head-to-head comparison of non-invasive coronary artery imaging

More information: "Prognostic Value of Combined CT Angiography and Myocardial Perfusion Imaging versus Invasive Coronary Angiography and Nuclear Stress Perfusion Imaging in the Prediction of Major Adverse Cardiovascular Events: The CORE320 Multicenter Study" Radiology, 2017.

Related Stories

Head-to-head comparison of non-invasive coronary artery imaging

August 29, 2016
For patients presenting for the first time with suspected coronary artery disease (CAD) clinicians have had a number of non-invasive diagnostic tests to choose from, but little evidence for which is best.

MRI stronger predictor of major adverse cardiovascular events than standard scan

May 9, 2016
Cardiovascular magnetic resonance (CMR) is a stronger predictor of risk for major adverse cardiovascular events (MACE) than single-photon emission computed tomography (SPECT) at 5 years follow-up. The findings are published ...

CT perfusion imaging better IDs CAD than SPECT

August 11, 2014
(HealthDay)—Computed tomographic (CT) perfusion imaging shows higher overall diagnostic performance than single photon emission computed tomography (SPECT) perfusion imaging for the diagnosis of coronary artery disease ...

CT angiography and perfusion to assess coronary artery disease: The CORE320 study

August 28, 2012
A non-invasive imaging strategy which integrates non-invasive CT angiography (CTA) and CT myocardial perfusion imaging (CTP) has robust diagnostic accuracy for identifying patients with flow-limiting coronary artery disease ...

Advanced CT imaging proves as accurate as invasive tests to assess heart blockages, study shows

November 19, 2013
An ultrafast, 320-detector computed tomography (CT) scanner that shows both anatomy within coronary arteries and blood flowcan accurately sort out which people need – or don't need – an invasive procedure to identify ...

Study examines unnecessary angiography rates among strategies to guide care of suspected CHD

August 29, 2016
In a study published online by JAMA, John P. Greenwood, Ph.D., of the University of Leeds, Leeds, United Kingdom, and colleagues examined whether among patients with suspected coronary heart disease (CHD), cardiovascular ...

Recommended for you

Could aggressive blood pressure treatments lead to kidney damage?

July 18, 2017
Aggressive combination treatments for high blood pressure that are intended to protect the kidneys may actually be damaging the organs, new research from the University of Virginia School of Medicine suggests.

Quantifying effectiveness of treatment for irregular heartbeat

July 17, 2017
In a small proof-of-concept study, researchers at Johns Hopkins report a complex mathematical method to measure electrical communications within the heart can successfully predict the effectiveness of catheter ablation, the ...

Concerns over side effects of statins stopping stroke survivors taking medication

July 17, 2017
Negative media coverage of the side effects associated with taking statins, and patients' own experiences of taking the drugs, are among the reasons cited by stroke survivors and their carers for stopping taking potentially ...

Study discovers anticoagulant drugs are being prescribed against safety advice

July 17, 2017
A study by researchers at the University of Birmingham has shown that GPs are prescribing anticoagulants to patients with an irregular heartbeat against official safety advice.

Protein may protect against heart attack

July 14, 2017
DDK3 could be used as a new therapy to stop the build-up of fatty material inside the arteries

Heart study finds faulty link between biomarkers and clinical outcomes

July 14, 2017
Surrogate endpoints (biomarkers), which are routinely used in clinical research to test new drugs, should not be trusted as the ultimate measure to approve new health interventions in cardiovascular medicine, according to ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.